Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
---|
01/14/2009 | EP2014677A1 A-33 related antigens and their pharmacological uses |
01/14/2009 | EP2014652A1 Activating agent for peroxisome proliferator activated receptor |
01/14/2009 | EP2014290A2 Use of tenatoprazole for the treatment of gastroesophageal reflux disease |
01/14/2009 | EP2014288A1 Combination of benzyl-4, 5-dihydro-1H-imidazole derivative and an opioid receptor ligand |
01/14/2009 | EP2014283A1 Anti-inflammatory agent and cancer-preventive agent comprising canolol or prodrug thereof and pharmaceutical, cosmetic and food comprising the same |
01/14/2009 | EP2013197A1 Phenethanolamine derivatives as beta2 adrenoreceptor agonists |
01/14/2009 | EP2013172A1 New alkyl esters of cyclic amino alcohols with muscarinic m3 receptor antagonist activity, useful for treating e.g. chronic bronchial obstruction, asthma and overactive bladder |
01/14/2009 | EP2012765A2 Compositions and methods useful for treatment of respiratory illness |
01/14/2009 | EP2012760A2 Purine derivatives for use as adenosin a2a receptor agonists |
01/14/2009 | EP2012759A1 Purine derivatives as a2a receptor agonists |
01/14/2009 | EP2012758A2 Inhibitors of the task-1 and task-3 ion channel |
01/14/2009 | EP1844050B1 Pyrrolopyrimidines useful as inhibitors of protein kinase |
01/14/2009 | EP1651221B1 Medicaments for inhalation comprising betamimetics and an anticholinergic agent |
01/14/2009 | EP1646365B1 Powdery formulations for inhalation, containing a novel anticholinergic agent |
01/14/2009 | EP1345899B1 N-substituted amides as NK1 receptor antagonists |
01/14/2009 | EP1317443B1 Chemokine receptor binding heterocyclic compounds |
01/14/2009 | EP1131337B1 Novel betulinic acid derivatives, processes for preparing such derivatives and its use as cancer growth inhibitors |
01/14/2009 | EP1115877B1 Polynucleotide constructs and uses thereof |
01/14/2009 | EP1107775B2 Composition containing pyrrolizidine-alkaloid-free petasites |
01/14/2009 | EP0841937B2 Use of betaglycan to reduce scarring |
01/14/2009 | CN201179204Y Bullough pseudoephedrine sustained-release capsules |
01/14/2009 | CN101346369A Pyrazinoylguanidine compounds useful in the treatment of inflammatory or allergic conditions |
01/14/2009 | CN101343324A Method for the inhibition of human TNF alpha activity |
01/14/2009 | CN101343218A Bipolarity trans-carotenoid salt and uses thereof |
01/14/2009 | CN101342350A Medicament for treating lithiasis |
01/14/2009 | CN101342334A Traditional Chinese medicine pill for treating common cold and cough |
01/14/2009 | CN101342333A Traditional Chinese medicine for treating cough and asthma and preparation method thereof |
01/14/2009 | CN101342331A Traditional Chinese medicine for treating pulmonitis and upper respiratory tract infection |
01/14/2009 | CN101342328A Traditional Chinese medicine composing prescription for treating children's bacterial upper respiratory tract infection |
01/14/2009 | CN101342327A Traditional Chinese medicine composing prescription for treating children's upper respiratory tract infection |
01/14/2009 | CN101342323A Medicine tea for treating common cold and preparation thereof |
01/14/2009 | CN101342312A Medicament for treating pharyngitis and method for preparing the same |
01/14/2009 | CN101342306A Traditional Chinese medicine preparation for treating cough diseases and preparation method thereof |
01/14/2009 | CN101342302A Traditional Chinese medicine composing prescription for treating children's upper respiratory tract infection fever |
01/14/2009 | CN101342283A Traditional Chinese medicine preparation for treating chronic trachitis |
01/14/2009 | CN101342280A Chinese medicine externally used paste for curing bronchial asthma and preparation method thereof |
01/14/2009 | CN101342277A Externally used antimicrobial spray for treating snore and preparation method thereof |
01/14/2009 | CN101342275A Medicament for preventing and controlling aspergillus disease of chicken |
01/14/2009 | CN101342250A Bolus for clearing away heat of the upper part of the body |
01/14/2009 | CN101342227A Medical use of soybean saponin and purification process thereof |
01/14/2009 | CN101342210A Mother chrysanthemum total flavone buccal tablets and preparation method thereof |
01/14/2009 | CN101342203A Anti-cancer medicine compound lychee formulation and preparation method thereof |
01/14/2009 | CN101342156A Gernebcin inhalation dust cloud agent |
01/14/2009 | CN101342155A (R,R)-formoterol inhalation dust cloud agent and preparation method thereof |
01/14/2009 | CN101341997A Snow pear beverage and preparation technique |
01/14/2009 | CN100451018C Novel quinuclidine derivatives and medicinal compositions containing the same |
01/14/2009 | CN100450504C Medication for treating pharyngitis |
01/14/2009 | CN100450503C Chinese traditional medicine for treating cough and variable asthma after cold and its preparation |
01/14/2009 | CN100450500C Medicinal composition for treating and preventing nasal sinusitis and preparing method |
01/14/2009 | CN100450488C Soft steroid compositions for use in dry powder inhalers |
01/14/2009 | CN100450371C Throat clearing tea and its preparing method |
01/13/2009 | US7476744 Polymorphic crystalline forms of celecoxib |
01/13/2009 | US7476688 Cyclic amidine derivatives |
01/13/2009 | US7476661 for treating basal cell carcinomas, medulloblastomas, and tumors |
01/13/2009 | US7476380 Using vitamin A and/or the derivatives and/or the esters for therapy and prophylaxis, side effect reduction |
01/13/2009 | CA2423280C Inhibitors of cyclic guanosine 3', 5'-monophosphates specific phosphodiesterase |
01/13/2009 | CA2390631C Carboxamide-substituted benzimidazole derivatives, processes for preparing them and their use as pharmaceutical compositions |
01/13/2009 | CA2315975C Phospholipid-coated microcrystals for the sustained release of pharmacologically active compounds and methods of their manufacture and use |
01/13/2009 | CA2271276C Pure enantiomer basic aryl-cycloalkyl-hydroxycarboxylic acid esters, process for preparing the same and their use in medicaments |
01/13/2009 | CA2216542C 1,3-dihydro-2h-imidazol-2-one derivatives having pde iv and cytokinin inhibiting activity |
01/08/2009 | WO2009006315A1 Modulators of atp-binding cassette transporters for treating cystic fibrosis |
01/08/2009 | WO2009005877A2 Alpha-i antitrypsin having no significant serine protease inhibitor activity |
01/08/2009 | WO2009005045A1 Substituted dihydroisoquinoline derivative |
01/08/2009 | WO2009004379A1 Novel compounds 951: a biphenyloxypropanoic acid as crth2 modulator and intermediates |
01/08/2009 | WO2009004374A1 Process for introduction of hydroxyethoxy side chain in bosentan |
01/08/2009 | WO2009004339A2 Modulation of reactive oxygen species in the treatment of respiratory infection |
01/08/2009 | WO2009003289A1 Small molecule correctors of deltaf508 cftr trafficking |
01/08/2009 | WO2008144720A3 Inhibitors of igf-1r signaling for the treatment of respiratory disorders |
01/08/2009 | WO2008140653A9 Humaneered anti-factor b antibody |
01/08/2009 | WO2008102128A3 Pharmaceutical combinations of at least two bronchodilators or of a bronchodilator with a corticosteroid |
01/08/2009 | WO2008012338A3 Pharmaceutical formulations comprising azelastine and a corticosteroid for the treatment of inflammatory or allergic conditions |
01/08/2009 | WO2007134827A8 5-phenyl-thiaz0l-2-yl-urea derivatives and use as pi3 kinase inhibitors |
01/08/2009 | WO2007118198A8 2-METHYLENE-1α,25-DIHYDROXY-19,21-DINORVITAMIN D3 ANALOGS AND USES THEREOF |
01/08/2009 | US20090012149 Prodrug of an ice inhibitor |
01/08/2009 | US20090012146 Solubility-enhanced pharmaceutical compositions comprising zafirlukast |
01/08/2009 | US20090012122 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
01/08/2009 | US20090012102 Imidazo[1,2-C]Pyrimidinylacetic Acid Derivatives |
01/08/2009 | US20090012083 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
01/08/2009 | US20090012079 Triazolopyridine Compounds |
01/08/2009 | US20090012073 N-aroyl cyclic amines |
01/08/2009 | US20090012065 Therapeutic applications of pro-apoptotic benzodiazepines |
01/08/2009 | US20090012063 Novel imidazole derivatives |
01/08/2009 | US20090012041 Use of cyclodextrin for treatment and prevention of bronchial inflammatory diseases |
01/08/2009 | US20090012027 Biodegradable polyphosphoramidates for controlled release of bioactive substances |
01/08/2009 | US20090012012 Intratracheal administration of endothelin-suppressing agents for the treatment of respiratory disorders |
01/08/2009 | US20090012006 Par-2 Antagonists |
01/08/2009 | US20090011010 Controlled release and taste masking oral pharmaceutical composition |
01/08/2009 | US20090010992 Drug formulations for oral transmucosal delivery to pediatric patients |
01/08/2009 | US20090010925 Antibody variants |
01/08/2009 | US20090010914 Use of Oligouronates for Treating Mucus Hyperviscosity |
01/08/2009 | US20090010912 Use of Alkaline Phosphatase for the Detoxification of Lps Present at Mucosal Barriers |
01/08/2009 | CA2728985A1 Modulators of atp-binding cassette transporters for treating cystic fibrosis |
01/08/2009 | CA2728366A1 Small molecule correctors of deltaf508 cftr trafficking |
01/08/2009 | CA2722015A1 Compositions and methods of use for alpha-1 antitrypsin having no significant serine protease inhibitor activity |
01/08/2009 | CA2694242A1 Process for introduction of hydroxyethoxy side chain in bosentan |
01/08/2009 | CA2691615A1 Novel compounds 951: a biphenyloxypropanoic acid as crth2 modulator and intermediates |
01/08/2009 | CA2681813A1 Transcription factor modulating compounds and methods of use thereof |
01/07/2009 | EP2011877A2 Conjugates for the modulation of immune responses |
01/07/2009 | EP2011505A1 Thioredoxin production promoting agent |
01/07/2009 | EP2011499A2 Pyrrolo[2,3d]Pyrimidine compositions and their use |